1,42 $US-20,5 %clôture 13 nov.
The latest quarter (ended 30 septembre 2026) is from Tenon Medical’s earnings press release of 12 novembre 2026. It will be replaced by the official quarterly report (10-Q) once Tenon Medical files it.
Just reported
From Tenon Medical, Inc's results release of 12 novembre 2026. These are the company's first figures; its 10-Q or 10-K replaces them when filed.
Actual
1,4M $US
+22 % y/y
+12 % q/q
Guided
—
No guide given
Actual
-3,1M $US
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
| Mesure | 3 mois au30 sept. 2026 | 3 mois au30 sept. 2025 | Variation |
|---|---|---|---|
| Chiffre d’affaires total | 1,4M $US | 1,2M $US | +22,08 % |
Ce sont des trimestres isolés, pas une année glissante — les chiffres ailleurs sur ce site couvrent douze mois et seront bien plus grands. Une activité saisonnière oscille beaucoup entre les deux : ServiceNow dégage 2,0 Md$ de flux de trésorerie disponible au trimestre de décembre et 0,5 Md$ à celui de juin.
Comparé au même trimestre un an plus tôt, et non à une prévision d’analystes. Un « beat » ou un « miss » suppose un consensus, une donnée sous licence que nous n’avons pas — et se tromper est pire que de s’abstenir.
Tenon Medical, Inc reported on 12 novembre 2026. We are fetching the call transcript; its summary follows once the transcript is in.
“Third quarter revenue of $1.4 million grew 22% compared to the prior year and 12% sequentially from the second quarter, and we delivered that growth while reducing operating expenses compared to both the third quarter of 2025 and the second quarter of this year,”
Cité mot pour mot du communiqué, et affiché uniquement lorsque le document l’attribue à une personne nommée.
Les communiqués tombent avant l’ouverture ou après la clôture : la fenêtre va donc de la clôture précédant le jour du communiqué à la clôture de la séance suivante, et contient la réaction dans les deux cas.
Tenon Medical, Inc. is a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders. Tenon was incorporated in the State of Delaware in 2012 and currently offers two systems to treat a diseased sacroiliac joint (the “SI Joint”). The Company has developed The Catamaran ® SI Joint Fusion System (“The Catamaran System”) that offers a novel, less invasive approach to the SI Joint using a single, robust titanium implant. In August 2025, the Company acquired substantially all the assets of SiVantage, Inc. and SIMPL Medical, LLC, including the SImmetry+ ® SI Joint Fusion System, which treats disorders of the SI Joint through a minimally invasive lateral access solution that incorporates well-established orthopedic fusion principles. Since the national launch of The Catamaran System in October 2022, Tenon has been focused on three commercial opportunities: 1) primary SI Joint procedures, 2) revision procedures of failed SI Joint implants and 3) SI-Joint fusion adjunct to a spine fusion construct.
La description que l’entreprise donne d’elle-même, telle qu’elle figure au bas du communiqué.
The quote, the company description and the latest quarter come from Tenon Medical’s earnings press release (an Item 2.02 8-K) filed 12 novembre 2026. Earlier quarters come from its quarterly and annual reports, and the latest will be replaced once the official report is filed. Lire le communiqué sur EDGAR Les cours sont ajustés des divisions d’actions et des dividendes.